Vera Therapeutics Inc Class A (VERA)
SG&A Expense Growth
33.97%
Quarterly · Period ending:
VERA SG&A Expense Growth
Latest reported33.97%period ending
Latest reported33.97%period ending
VERA Quarterly SG&A Growth (QoQ) (0.00% → 33.97%)
Latest values, visible window
High-resolution chart · PNG
VERA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 33.969% | |
| 12.1074% | |
| 27.084% | |
| 25.1208% | |
| 37.8864% | |
| 2.2419% | |
| 64.0877% | |
| 18.115% | |
| 8.6139% | |
| 29.487% | |
| 0.9724% | |
| -1.4462% | |
| -6.6829% | |
| -10.9341% | |
| 23.5684% | |
| 13.003% | |
| 10.5769% | |
| 16.7015% | |
| 3.9046% | |
| 41.0865% | |
| 46.5247% | |
| 57.0423% | |
| 74.2331% | |
| -46.5135% | |
| 18.1202% | |
| 0% |